Literature DB >> 18442341

Multiple sclerosis: impact of physical activity on psychosocial constructs.

Matthew A Plow1, Virgil Mathiowetz, Linda Resnik.   

Abstract

OBJECTIVES: To determine the impact of physical activity (PA) interventions and experience with PA on psychosocial constructs.
METHODS: PA, self-efficacy, self-identity, social support, and expected PA frequency were measured pre and post intervention in 39 persons with multiple sclerosis.
RESULTS: The MANOVA analysis indicated that self-efficacy and expectation decreased, whereas self-identity and PA improved (P<0.05). Regressions analyses indicated pretest self-identity (beta(2)=0.44) and social support (beta(2)=0.34) were associated with PA. Posttest self-efficacy (beta(2)=0.38) and social support (beta(2)=0.31) were associated with PA (P<0.05).
CONCLUSIONS: The interventions and experience with PA caused changes in psychosocial constructs, which subsequently affected the correlation of these constructs with PA.

Entities:  

Mesh:

Year:  2008        PMID: 18442341     DOI: 10.5555/ajhb.2008.32.6.614

Source DB:  PubMed          Journal:  Am J Health Behav        ISSN: 1087-3244


  4 in total

1.  Potential benefits of nintendo wii fit among people with multiple sclerosis: a longitudinal pilot study.

Authors:  Matthew Plow; Marcia Finlayson
Journal:  Int J MS Care       Date:  2011

2.  A Qualitative Study of Multiple Health Behaviors in Adults with Multiple Sclerosis.

Authors:  Matthew A Plow; Meghan Golding
Journal:  Int J MS Care       Date:  2016 Sep-Oct

3.  Exploring physical activity behaviour of persons with multiple sclerosis: a qualitative pilot study.

Authors:  Matthew A Plow; Linda Resnik; Susan M Allen
Journal:  Disabil Rehabil       Date:  2009       Impact factor: 3.033

4.  Significance and potential of self-management research for HTLV-1 associated myelopathy: review of self-management for people with multiple sclerosis.

Authors:  Saori Yamaguchi; Rika Yatsushiro
Journal:  J Rural Med       Date:  2019-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.